Literature DB >> 18456573

Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases.

Grace Lai-Hung Wong1, Vincent Wai-Sun Wong, Paul Cheung-Lung Choi, Anthony Wing-Hung Chan, Richard Hoi-Leong Chum, Henry Kai-Wing Chan, Kenneth Ka-Ki Lau, Angel Mei-Ling Chim, Karen Ka-Lam Yiu, Francis Ka-Leung Chan, Joseph Jao-Yao Sung, Henry Lik-Yuen Chan.   

Abstract

BACKGROUND & AIMS: Liver stiffness measurement (LSM) with transient elastography (Fibroscan) can accurately diagnose advanced liver fibrosis, but its performance in early liver fibrosis is less satisfactory. We aimed to study the diagnostic performance of LSM for histologic bridging fibrosis and cirrhosis in various chronic liver diseases and to investigate the effects of liver fibrosis distribution on LSM.
METHODS: We prospectively studied consecutive patients with chronic liver diseases undergoing liver biopsy and transient elastography examinations. Morphometric analysis was performed to evaluate the distribution of liver fibrosis.
RESULTS: One hundred thirty-three patients (50% chronic hepatitis B, 14% chronic hepatitis C, and 24% nonalcoholic fatty liver disease) were studied. Morphometric analysis revealed a higher correlation between LSM and pericellular fibrosis (r = 0.43) than periportal (r = 0.21) or perivenular fibrosis (r = 0.25). Area under receiver operating characteristic curve (ROC) of LSM for bridging fibrosis was 0.87 (95% confidence interval, 0.81-0.93) and for cirrhosis was 0.89 (95% confidence interval, 0.83-0.94). Higher LSM was associated with higher serum ALT level. Patients with the same fibrosis staging but higher ALT levels tend to have higher LSM. The area under ROC curve of LSM for cirrhosis was lower among patients who had ALT above the upper limit of normal (0.86) as compared with that of patients with normal ALT levels (0.93, P = .03).
CONCLUSIONS: Transient elastography can diagnose severe fibrosis because of its good correlation with pericellular fibrosis. Transient elastography might overestimate liver fibrosis when ALT is elevated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456573     DOI: 10.1016/j.cgh.2008.02.038

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  35 in total

1.  FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.

Authors:  Keyur Patel; Mireen Friedrich-Rust; Yoav Lurie; Mircea Grigorescu; Carol Stanciu; Chuan-Mo Lee; Eugene R Schiff; Dieter Häussinger; Michael P Manns; Guido Gerken; Isabelle Colle; Michael Torbenson; Erik Pulkstenis; G Mani Subramanian; John G McHutchison; Stefan Zeuzem
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

2.  Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection.

Authors:  Elliot B Tapper; Eric B Cohen; Keyur Patel; Bruce Bacon; Stuart Gordon; Eric Lawitz; David Nelson; Imad A Nasser; Tracy Challies; Nezam Afdhal
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

Review 3.  Liver elastography, comments on EFSUMB elastography guidelines 2013.

Authors:  Xin-Wu Cui; Mireen Friedrich-Rust; Chiara De Molo; Andre Ignee; Dagmar Schreiber-Dietrich; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 4.  Fatty liver in childhood.

Authors:  Yesim Ozturk; Ozlem Bekem Soylu
Journal:  World J Hepatol       Date:  2014-01-27

Review 5.  Acoustic radiation force elasticity imaging in diagnostic ultrasound.

Authors:  Joshua R Doherty; Gregg E Trahey; Kathryn R Nightingale; Mark L Palmeri
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2013-04       Impact factor: 2.725

6.  Transient elastography: Kill two birds with one stone?

Authors:  Grace Lai-Hung Wong
Journal:  World J Hepatol       Date:  2013-05-27

7.  Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.

Authors:  Felix Nickel; Christian Tapking; Laura Benner; Janina Sollors; Adrian T Billeter; Hannes G Kenngott; Loay Bokhary; Mathias Schmid; Moritz von Frankenberg; Lars Fischer; Sebastian Mueller; Beat P Müller-Stich
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

Review 8.  Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools.

Authors:  Yan Wang; Jin-Lin Hou
Journal:  Hepatol Int       Date:  2016-01-07       Impact factor: 6.047

9.  Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C.

Authors:  Jérôme Boursier; Victor de Ledinghen; Nathalie Sturm; Laïla Amrani; Yannick Bacq; Jérémy Sandrini; Brigitte Le Bail; Julien Chaigneau; Jean-Pierre Zarski; Yves Gallois; Vincent Leroy; Zaytouna Al Hamany; Frédéric Oberti; Isabelle Fouchard-Hubert; Nina Dib; Sandrine Bertrais; Marie-Christine Rousselet; Paul Calès
Journal:  J Gastroenterol       Date:  2013-05-17       Impact factor: 7.527

10.  Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?

Authors:  Behairy El-Sayed Behairy; Mostafa Mohamed Sira; Khaled Refat Zalata; El-Sayed Ebrahem Salama; Mohamed Ahmed Abd-Allah
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.